Cecilia Hellstrom

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Correction to: Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys.

Correction to: Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys.

Journal: The Journal of infectious diseases

Published: July 21, 2022

Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies.

Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies.

Journal: Journal of autoimmunity

Published: June 13, 2022

Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis.

Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis.

Journal: Science advances

Published: April 27, 2022

Multiomics Profiling of Alzheimer's Disease Serum for the Identification of Autoantibody Biomarkers.

Multiomics Profiling of Alzheimer's Disease Serum for the Identification of Autoantibody Biomarkers.

Journal: Journal of proteome research

Published: October 11, 2021

Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals.

Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals.

Journal: Med (New York, N.Y.)

Published: October 08, 2021

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.

Journal: Journal of internal medicine

Published: August 30, 2021

SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection.

SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection.

Journal: PloS one

Published: August 24, 2021

Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.

Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.

Journal: EBioMedicine

Published: May 20, 2021

A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies.

A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies.

Journal: New biotechnology

Published: May 20, 2021

Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys.

Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys.

Journal: The Journal of infectious diseases

Published: March 13, 2021

Multiomics and digital monitoring during lifestyle changes reveal independent dimensions of human biology and health.

Multiomics and digital monitoring during lifestyle changes reveal independent dimensions of human biology and health.

Journal: Cell systems

Published: February 11, 2021

Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay.

Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay.

Journal: Clinical & translational immunology

Published: February 10, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026